SGTI-flex COVID-19 IgM/IgG is a immunochromatographic test kit that qualitatively measures the IgM and IgG antibodies of COVID-19 in whole blood (fingertip blood or venous blood), serum or plasma.
This kit is accurate and easy to use
- CE-IVD
- ANVISA (Brazil)
7. Conclusion
Comparison studies between the test device (SGTi-flex COVID19 IgM/lgG) and the
predicate device (Reference method, real time RT-PCR) were conducted by lab
professionals, using total 523 specimens.
The results showed the accuracy (Overalll percent agreement) was 97.13%.
The Séroconversion study confirmed that IgM was first generated in patients with negative
results for IgM or IgG antibodies in the early stages of infection, and that IgG was also
produced over time.
When estimating the sensitivity of IgM and IgG over time from symptom onset for ail
positive samples, the proportion of IgM positive patients reached a peak of 100.0%
approximately 15-21 days after symptom onset, whereas the proportion of IgG positive
patients reached 100% approximately 22 days after symptom onset.